Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Leakiness in Alcoholic Liver Disease
NCT05428072Phase 1Completed
- Sponsor
- Rush University Medical Center
- Start
- Jan 2003
- Primary completion
- Mar 2015
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Rush University Medical Center. Primary endpoints: Changes in gut permeability at 3 days and Changes in gut permeability after consuming aspirin at 1 day. Started Jan 2003; status: completed.
Beyond the preview
Go deeper on NCT05428072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05428072.